Dr. Atul Luthra

Consultant

43 Years of Experience

Diabetologist, Endocrinologist

MBBS, MD, DNB

Reg. No.:2488, Delhi Medical Council

English, Hindi

Consultation Fee ₹ 1500

Book Appointment

Dr. Atul Luthra is one of the renowned Endocrinologists with 43 years of tremendous experience in his field.
He has managed numerous complex medical cases, making him a trustworthy name among patients.
His specialty areas include managing diabetes, obesity, hypertension, lipid disorders, foot infections, diabetic ulcers, etc.
Dr. Luthra completed his MBBS in 1981 and earned his MD in Medicine in 1985 from Amritsar Medical College.
Later, he did his DNB in Endocrinology from the National Board of Examination in 1991.
He received the Rashtriya Rattan Award, the Arch Of Excellence (Medicare) Award, and the Coeur D’or” (Heart Of Gold) Award, in 2006.
Dr. Atul has also published multiple papers in national and international journals.

Get a Treatment Plan Within 1 Hour

Name*

Mobile Number*

Whatsapp Number *

Query

MBBS, Amritsar Medical College, Amritsar, 1981
MD (Internal Medicine), Amritsar Medical College, Amritsar, 1985
DNB (Endocrinology, Diabetes, Metabolism), National Board of Examination, New Delhi, 1991

Dr. Atul Luthra is one of the renowned Endocrinologists with 43 years of tremendous experience in his field.
He has managed numerous complex medical cases, making him a trustworthy name among patients.
His specialty areas include managing diabetes, obesity, hypertension, lipid disorders, foot infections, diabetic ulcers, etc.
Dr. Luthra completed his MBBS in 1981 and earned his MD in Medicine in 1985 from Amritsar Medical College.
Later, he did his DNB in Endocrinology from the National Board of Examination in 1991.
He received the Rashtriya Rattan Award, the Arch Of Excellence (Medicare) Award, and the Coeur D’or” (Heart Of Gold) Award, in 2006.
Dr. Atul has also published multiple papers in national and international journals.

Luthra, Atul & Misra, Anoop. (2020). The escalating cost of oral and injectable antihyperglycemic drugs; are newer medications worth their price? A perspective from India and other developing countries. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 14. 10.1016/j.dsx.2020.01.012.
Misra, Anoop & Mukherjee, Rupali & Luthra, Atul & Singh, Padam. (2017). Rising Costs of Drug/Insulin Treatment for Diabetes: A Perspective from India. Diabetes Technology & Therapeutics. 19. 10.1089/dia.2017.0286.
Misra, Anoop & Gulati, Seema & Luthra, Atul. (2016). Alternative medicines for diabetes in India: Maximum hype, minimum science. The Lancet Diabetes & Endocrinology. 4. 302-303. 10.1016/S2213-8587(15)00515-X.
Luthra, Atul & Misra, Anoop. (2016). Drug approvals in India – Authors' reply. The Lancet Diabetes & Endocrinology. 4. 20-21. 10.1016/S2213-8587(15)00479-9.
Misra, Anoop & Gulati, Seema & Luthra, Atul. (2016). Ayurveda for diabetes in India – Authors' reply. The Lancet Diabetes & Endocrinology. 4. 884-885. 10.1016/S2213-8587(16)30238-8.
Luthra, Atul & Misra, Anoop. (2015). The marketing of unproven drugs for diabetes and dyslipidemia in India. The Lancet. Diabetes & endocrinology. 3. 758-60. 10.1016/S2213-8587(15)00328-9.